Clinical significance of serum CA15-3 as a prognostic parameter during follow-up periods in patients with breast cancer
Authors:
Open Access
- 1 January 2016
- journal article
- Published by The Korean Surgical Society in Annals of Surgical Treatment and Research
- Vol. 90 (2) , 57-63
Abstract
Chu WG, et al. Ann Surg Treat Res. 2016 Feb;90(2):57-63. http://dx.doi.org/10.4174/astr.2016.90.2.57Keywords
This publication has 27 references indexed in Scilit:
- Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancerThe Breast, 2014
- Diagnostic Significance of CA15-3 with Combination of HER-2/neu Values at 85th Percentiles in Breast CancerIndian Journal of Clinical Biochemistry, 2012
- Novel automated flow-based immunosensor for real-time measurement of the breast cancer biomarker CA15-3 in serumTalanta, 2012
- Kinetics of CEA and CA15-3 correlate with treatment response in patients undergoing chemotherapy for metastatic breast cancer (MBC)Tumor Biology, 2011
- Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancerBreast Cancer Research and Treatment, 2009
- Breast Cancer Screening and Biomarkers2009
- CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancerBreast Cancer Research and Treatment, 1995
- Tumour marker CA15-3: possible uses in the routine management of breast cancerEuropean Journal of Cancer, 1995
- Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of diseaseEuropean Journal of Cancer, 1994
- The clinical value of serum CA15-3 assay postoperatively in breast cancer patientsSurgery Today, 1989